These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 30401714)

  • 1. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
    Yan X; Zhang X; Wang L; Zhang R; Pu X; Wu S; Li L; Tong P; Wang J; Meng QH; Jensen VB; Girard L; Minna JD; Roth JA; Swisher SG; Heymach JV; Fang B
    Cancer Res; 2019 Jan; 79(1):125-132. PubMed ID: 30401714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSR is not essential for the maintenance of antioxidant defenses in mouse cochlea: Possible role of the thioredoxin system as a functional backup for GSR.
    Han C; Kim MJ; Ding D; Park HJ; White K; Walker L; Gu T; Tanokura M; Yamasoba T; Linser P; Salvi R; Someya S
    PLoS One; 2017; 12(7):e0180817. PubMed ID: 28686716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.
    Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B
    Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.
    Dai B; Yoo SY; Bartholomeusz G; Graham RA; Majidi M; Yan S; Meng J; Ji L; Coombes K; Minna JD; Fang B; Roth JA
    Cancer Res; 2013 Sep; 73(17):5532-43. PubMed ID: 23824739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase.
    Malin D; Lee Y; Chepikova O; Strekalova E; Carlson A; Cryns VL
    Breast Cancer Res Treat; 2021 Dec; 190(3):373-387. PubMed ID: 34553295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth.
    Johnson SS; Liu D; Ewald JT; Robles-Planells C; Pulliam C; Christensen KA; Bayanbold K; Wels BR; Solst SR; O'Dorisio MS; Menda Y; Spitz DR; Fath MA
    Cancer Biol Ther; 2024 Dec; 25(1):2382524. PubMed ID: 39054566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells.
    Tanaka G; Inoue K; Shimizu T; Akimoto K; Kubota K
    Cancer Med; 2016 Sep; 5(9):2544-57. PubMed ID: 27485632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
    Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
    Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.
    Scarbrough PM; Mapuskar KA; Mattson DM; Gius D; Watson WH; Spitz DR
    Free Radic Biol Med; 2012 Jan; 52(2):436-43. PubMed ID: 22100505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression.
    Kinoshita H; Shimozato O; Ishii T; Kamoda H; Hagiwara Y; Tsukanishi T; Ohtori S; Yonemoto T
    Anticancer Res; 2021 Oct; 41(10):4947-4955. PubMed ID: 34593442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione reductase (
    Baity M; Wang L; Correa AM; Zhang X; Zhang R; Pataer A; Wu S; Meng QH; Antonoff MB; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Zhao M; Gu J; Fang B
    Am J Cancer Res; 2019; 9(6):1201-1211. PubMed ID: 31285952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.
    Sobhakumari A; Love-Homan L; Fletcher EV; Martin SM; Parsons AD; Spitz DR; Knudson CM; Simons AL
    PLoS One; 2012; 7(10):e48175. PubMed ID: 23118946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.
    Fujimori S; Abe Y; Nishi M; Hamamoto A; Inoue Y; Ohnishi Y; Nishime C; Matsumoto H; Yamazaki H; Kijima H; Ueyama Y; Inoue H; Nakamura M
    Int J Oncol; 2004 Aug; 25(2):413-8. PubMed ID: 15254739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate enhances key enzymatic activities of hepatic thioredoxin and glutathione systems in selenium-optimal mice but activates hepatic Nrf2 responses in selenium-deficient mice.
    Dong R; Wang D; Wang X; Zhang K; Chen P; Yang CS; Zhang J
    Redox Biol; 2016 Dec; 10():221-232. PubMed ID: 27810737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
    Roh JL; Jang H; Kim EH; Shin D
    Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-reciprocal regulation of the redox state of the glutathione-glutaredoxin and thioredoxin systems.
    Trotter EW; Grant CM
    EMBO Rep; 2003 Feb; 4(2):184-8. PubMed ID: 12612609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
    Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
    Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis.
    Zhu Z; Du S; Du Y; Ren J; Ying G; Yan Z
    J Neurochem; 2018 Jan; 144(1):93-104. PubMed ID: 29105080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action.
    Parsonage D; Sheng F; Hirata K; Debnath A; McKerrow JH; Reed SL; Abagyan R; Poole LB; Podust LM
    J Struct Biol; 2016 May; 194(2):180-90. PubMed ID: 26876147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione reductase gsr-1 is an essential gene required for Caenorhabditis elegans early embryonic development.
    Mora-Lorca JA; Sáenz-Narciso B; Gaffney CJ; Naranjo-Galindo FJ; Pedrajas JR; Guerrero-Gómez D; Dobrzynska A; Askjaer P; Szewczyk NJ; Cabello J; Miranda-Vizuete A
    Free Radic Biol Med; 2016 Jul; 96():446-61. PubMed ID: 27117030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.